Cite
DA-Raf, a dominant-negative regulator of the Ras-ERK pathway, is essential for skeletal myocyte differentiation including myoblast fusion and apoptosis
MLA
Eisuke Itakura, et al. “DA-Raf, a Dominant-Negative Regulator of the Ras-ERK Pathway, Is Essential for Skeletal Myocyte Differentiation Including Myoblast Fusion and Apoptosis.” Experimental Cell Research, vol. 376, no. 2, Nov. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d226329bd52eec6439a741e688a3e312&authtype=sso&custid=ns315887.
APA
Eisuke Itakura, Kazunori Takano, Takeshi Endo, & Kazuya Takahashi. (2018). DA-Raf, a dominant-negative regulator of the Ras-ERK pathway, is essential for skeletal myocyte differentiation including myoblast fusion and apoptosis. Experimental Cell Research, 376(2).
Chicago
Eisuke Itakura, Kazunori Takano, Takeshi Endo, and Kazuya Takahashi. 2018. “DA-Raf, a Dominant-Negative Regulator of the Ras-ERK Pathway, Is Essential for Skeletal Myocyte Differentiation Including Myoblast Fusion and Apoptosis.” Experimental Cell Research 376 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d226329bd52eec6439a741e688a3e312&authtype=sso&custid=ns315887.